The Duxes Compliance and Risk series features annual events in China, as well as across the Asia Pacific region and Middle East, gathering industry leaders and policymakers to discuss the latest developments in the field of anti-corruption compliance.
The Australian Trade Commission (Austrade) issued a guidance for Australians doing business overseas in 2018, providing practical guidance for establishing a culture of compliance and managing bribery and corruption risks within organizations.
On January 29, 2019, Transparency International released the 2018 edition of its Corruption Perceptions Index (CPI). Unfortunately, it does not bring good news. More than two-thirds scored below 50 (100 means no corruption), with an average score of 43.
For the first time in more than two decades, Chinese regulators have revised the Anti-Unfair Competition Law to give companies a clearer picture of what constitutes commercial bribery, a development that increases compliance risks for multinational corporations in China.
As more companies look to expand their presence in the Chinese market, they face an inevitable challenge——corruption. Compliance-related risk should be a top priority for corporate officers, as China's anti-corruption campaign has reached a new crescendo in recent years.
Duxes hosted the 4th Anti-Corruption Compliance EMEA Summit 2018 on November 14-15 in Dubai. The event featured significant testimony from policymakers, legal experts, compliance officers, and representatives of NGOs, shedding light on the developing anti-corruption environment in the Middle East, A ...
On November 4, 2017, the thirtieth meeting of the 12th Standing Committee of the National People's Congress voted to adopt the revised Anti-unfair Competition Law, which came into effect on January 1, 2018.
At the end of July, a vaccine scandal shocked China and exposed serious commercial bribery problems in the pharmaceutical industry. The 20th meeting of the interministerial joint conference was held in Beijing to rectify the situation and address unethical practices in the medical industry. The meet ...